They are focused on delivering mobile software apps in multiple clinical settings including telehealth, emergency, urgent care and primary care.
The design consultancy will work with leading UK-based medical device manufacturers, OSI Electronics, to design, test and finalise two CE-marked devices.
They include a lowcosthandheld device and a small, wearable breathing monitor.
The wearable monitor will provide ResApp with an easily worn, unobtrusive platform for monitoring patients with chronic disease 24/7 over extended periods.
Shares in ResApp Health 16.67 per cent higher at $0.175 yesterday.